Search This Blog

Wednesday, August 7, 2019

Intercept Pharma EPS beats by $0.33, beats on revenue

Intercept Pharma (NASDAQ:ICPT): Q2 GAAP EPS of -$2.28 beats by $0.33.
Revenue of $66.3M (+52.1% Y/Y) beats by $7.52M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)